Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Horby et al., Lancet Infectious Diseases, doi:10.1016/S1473-3099(25)00361-5 (preprint 1/27/2025)
https://c19early.org/horby3.html